Open AccessRAGE-specific single chain Fv for PET imaging of pancreatic cancer
Author(s) -
Hye Yeong Kim,
Xiaolei Wang,
Rui Kang,
Daolin Tang,
Brian A. Boone,
Herbert J. Zeh,
Michael T. Lotze,
Wilson B. Edwards
Publication year - 2018
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0192821
Subject(s) - rage (emotion) , pancreatic cancer , biodistribution , cancer research , medicine , pancreas , pathology , positron emission tomography , cancer , in vivo , biology , nuclear medicine , neuroscience , microbiology and biotechnology
Noninvasive detection of both early pancreatic neoplasia and metastases could enhance strategies to improve patient survival in this disease that is notorious for an extremely poor prognosis. There are almost no identifiable targets for non-invasive diagnosis by positron emission tomography (PET) for patients with pancreatic ductal adenocarcinoma (PDAC). Over-expression of the receptor for advanced glycation end products (RAGE) is found on the cell surface of both pre-neoplastic lesions and invasive PDAC. Here, a RAGE-specific single chain (scFv) was developed, specific for PET imaging in syngeneic mouse models of PDAC. An anti-RAGE scFv conjugated with a sulfo-Cy5 fluorescence molecule showed high affinity and selectivity for RAGE expressing pancreatic tumor cells and genetically engineered KRAS G12D mouse models of PDAC. An in vivo biodistribution study was performed with the 64 Cu-radiolabled scFv in a syngeneic murine pancreatic cancer model, demonstrating both the feasibility and potential of an anti-RAGE scFv for detection of PDAC. These studies hold great promise for translation into the clinic.